Medpace Holdings Stock Performance
MEDP Stock | USD 385.05 2.09 0.54% |
On a scale of 0 to 100, Medpace Holdings holds a performance score of 6. The company secures a Beta (Market Risk) of 1.43, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Medpace Holdings will likely underperform. Please check Medpace Holdings' value at risk, and the relationship between the jensen alpha and skewness , to make a quick decision on whether Medpace Holdings' current price movements will revert.
Risk-Adjusted Performance
6 of 100
Weak | Strong |
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Medpace Holdings are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Even with relatively fragile fundamental indicators, Medpace Holdings reported solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (0.54) | Five Day Return (3.43) | Year To Date Return 26 | Ten Year Return 1.3 K | All Time Return 1.3 K |
1 | Sale by August Troendle of 53385 shares of Medpace Holdings | 09/20/2023 |
2 | Sale by August Troendle of 65653 shares of Medpace Holdings | 09/21/2023 |
3 | Sale by August Troendle of 25000 shares of Medpace Holdings | 11/16/2023 |
4 | Sale by August Troendle of 50000 shares of Medpace Holdings | 11/21/2023 |
5 | Sale by August Troendle of 3167 shares of Medpace Holdings | 12/01/2023 |
6 | Disposition of 50000 shares by August Troendle of Medpace Holdings at 1.75 subject to Rule 16b-3 | 02/16/2024 |
7 | Disposition of 13988 shares by August Troendle of Medpace Holdings at 386. subject to Rule 16b-3 | 02/20/2024 |
8 | Disposition of 50000 shares by Medpace Investors, Llc of Medpace Holdings at 404.13 subject to Rule 16b-3 | 02/28/2024 |
9 | Director Ashley Keating Sells Shares of Medpace Holdings Inc | 02/29/2024 |
10 | Disposition of 250 shares by Ashley Keating of Medpace Holdings at 409.87 subject to Rule 16b-3 | 03/14/2024 |
11 | Does Medpace Holdings Have The Potential to Maintain Strong Growth | 03/19/2024 |
12 | Investors in Medpace Holdings have seen enviable returns of 609 percent over the past five years | 03/22/2024 |
13 | Medpace Holdings stock performs better than its underlying earnings growth over last five years | 03/27/2024 |
14 | Disposition of tradable shares by Brian Carley of Medpace Holdings subject to Rule 16b-3 | 03/28/2024 |
15 | If You Invested 1000 In This Stock 5 Years Ago, You Would Have 6,500 Today | 04/02/2024 |
16 | Medpace Holdings is Maintaining a Healthy Margin Profile | 04/05/2024 |
17 | Why HCA Healthcare is a Smart Addition to Your Portfolio | 04/09/2024 |
18 | Does Medpace Holdings Deserve A Spot On Your Watchlist | 04/12/2024 |
19 | Medpace Earnings Expected to Grow Should You Buy | 04/15/2024 |
Begin Period Cash Flow | 28.3 M |
Medpace |
Medpace Holdings Relative Risk vs. Return Landscape
If you would invest 13,186 in Medpace Holdings on January 18, 2024 and sell it today you would earn a total of 25,319 from holding Medpace Holdings or generate 192.01% return on investment over 90 days. Medpace Holdings is currently generating 0.2594% in daily expected returns and assumes 3.0356% risk (volatility on return distribution) over the 90 days horizon. In different words, 26% of stocks are less volatile than Medpace, and 95% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
Risk |
Medpace Holdings Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Medpace Holdings' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Medpace Holdings, and traders can use it to determine the average amount a Medpace Holdings' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0854
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | MEDP | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
3.04 actual daily | 26 74% of assets are more volatile |
Expected Return
0.26 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
0.09 actual daily | 6 94% of assets perform better |
Based on monthly moving average Medpace Holdings is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Medpace Holdings by adding it to a well-diversified portfolio.
Medpace Holdings Fundamentals Growth
Medpace Stock prices reflect investors' perceptions of the future prospects and financial health of Medpace Holdings, and Medpace Holdings fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Medpace Stock performance.
Return On Equity | 0.6 | ||||
Return On Asset | 0.14 | ||||
Profit Margin | 0.15 % | ||||
Operating Margin | 0.18 % | ||||
Current Valuation | 11.83 B | ||||
Shares Outstanding | 30.98 M | ||||
Price To Earning | 49.07 X | ||||
Price To Book | 21.90 X | ||||
Price To Sales | 6.49 X | ||||
Revenue | 1.89 B | ||||
Gross Profit | 925.11 M | ||||
EBITDA | 365.08 M | ||||
Net Income | 282.81 M | ||||
Cash And Equivalents | 31.01 M | ||||
Cash Per Share | 1.00 X | ||||
Total Debt | 142.12 M | ||||
Debt To Equity | 0.85 % | ||||
Current Ratio | 0.41 X | ||||
Book Value Per Share | 18.22 X | ||||
Cash Flow From Operations | 433.37 M | ||||
Earnings Per Share | 8.87 X | ||||
Market Capitalization | 11.99 B | ||||
Total Asset | 1.66 B | ||||
Retained Earnings | (221.65 M) | ||||
Working Capital | (331.3 M) | ||||
Current Asset | 94.72 M | ||||
Current Liabilities | 134.02 M | ||||
About Medpace Holdings Performance
To evaluate Medpace Holdings Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Medpace Holdings generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Medpace Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Medpace Holdings market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Medpace's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.Last Reported | Projected for Next Year | ||
Days Of Inventory On Hand | 0.00000059 | 0.000001 | |
Return On Tangible Assets | 0.30 | 0.16 | |
Return On Capital Employed | 0.46 | 0.48 | |
Return On Assets | 0.17 | 0.18 | |
Return On Equity | 0.51 | 0.53 |
Things to note about Medpace Holdings performance evaluation
Checking the ongoing alerts about Medpace Holdings for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Medpace Holdings help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Medpace Holdings had very high historical volatility over the last 90 days | |
Medpace Holdings is unlikely to experience financial distress in the next 2 years | |
The company currently holds 142.12 M in liabilities with Debt to Equity (D/E) ratio of 0.85, which is about average as compared to similar companies. Medpace Holdings has a current ratio of 0.4, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Medpace Holdings until it has trouble settling it off, either with new capital or with free cash flow. So, Medpace Holdings' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Medpace Holdings sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Medpace to invest in growth at high rates of return. When we think about Medpace Holdings' use of debt, we should always consider it together with cash and equity. | |
Medpace Holdings has a very strong financial position based on the latest SEC filings | |
Over 83.0% of Medpace Holdings shares are owned by institutional investors | |
Latest headline from zacks.com: Medpace Earnings Expected to Grow Should You Buy |
- Analyzing Medpace Holdings' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Medpace Holdings' stock is overvalued or undervalued compared to its peers.
- Examining Medpace Holdings' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Medpace Holdings' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Medpace Holdings' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Medpace Holdings' stock. These opinions can provide insight into Medpace Holdings' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medpace Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. To learn how to invest in Medpace Stock, please use our How to Invest in Medpace Holdings guide.Note that the Medpace Holdings information on this page should be used as a complementary analysis to other Medpace Holdings' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Complementary Tools for Medpace Stock analysis
When running Medpace Holdings' price analysis, check to measure Medpace Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medpace Holdings is operating at the current time. Most of Medpace Holdings' value examination focuses on studying past and present price action to predict the probability of Medpace Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medpace Holdings' price. Additionally, you may evaluate how the addition of Medpace Holdings to your portfolios can decrease your overall portfolio volatility.
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Transaction History View history of all your transactions and understand their impact on performance | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |
Is Medpace Holdings' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medpace Holdings. If investors know Medpace will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medpace Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.165 | Earnings Share 8.87 | Revenue Per Share 61.384 | Quarterly Revenue Growth 0.265 | Return On Assets 0.1399 |
The market value of Medpace Holdings is measured differently than its book value, which is the value of Medpace that is recorded on the company's balance sheet. Investors also form their own opinion of Medpace Holdings' value that differs from its market value or its book value, called intrinsic value, which is Medpace Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medpace Holdings' market value can be influenced by many factors that don't directly affect Medpace Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Medpace Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Medpace Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medpace Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.